Sath Shukla, CEO & President at Spero Therapeutics, Inc. (SPRO), sold 2,757 shares at $1.35 ($4K) on 2024-08-27, disclosed to the SEC on 2024-08-29.
Seasonal sale ($4k) by CEO & President — this insider has traded SPRO in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SPRO | SELL | 2024-02-05 | $173K | — | Filing → |
| SPRO | SELL | 2023-08-30 | $8K | — | Filing → |
| SPRO | SELL | 2023-02-03 | $17K | — | Filing → |